New insights on the structural biology of medical cannabis
French researchers underwent a structural study showing that THC cannabinoids inhibit a human enzyme called autotaxin.
List view / Grid view
French researchers underwent a structural study showing that THC cannabinoids inhibit a human enzyme called autotaxin.
In this article, Drug Target Review’s Izzy Wood reviews some of the latest Alzheimer's disease research, highlighting the progress that has been made toward new, more unique therapeutic strategies against Alzheimer’s.
US researchers have developed a mouse model that holds promise in identifying the best organ donor and showing early signs of transplant rejection.
Dutch researchers, using optogenetic approaches and an asthma drug, discovered that memory loss from sleep deprivation can be retrieved.
Japanese researchers reported that a key transcription factor “Nrf3” regulates the process of melanin production in mouse and human cells.
Cell proliferation assays are a cornerstone of cancer therapeutic, developmental biology, and drug safety research.
US scientists, using high-resolution imaging, debuted a new way to see cell organisation and rich variation in cell shape
Discover how Catalent can help you achieve efficiencies and develop a robust, reproducible manufacturing plan for late-stage and commercial launch.
Chinese scientists have developed a synthetic tissue that repairs penile injuries and restores normal erectile function in pigs.
The researchers explored the possibility of using the probiotic bacteria Lactobacillus reuteri as a novel oral drug delivery platform to treat rheumatoid arthritis in an animal model.
US scientists offer a new purpose for the blood pressure drug clonidine as a treatment to reduce the affects of PTSD.
Development of novel rabbit monoclonal antibodies to characterise microglial activation states in murine models of Alzheimer’s disease.
The researchers found that the protein Grb10 promotes leptin activity in the brain, opening the possibility of developing Grb10-based new approaches to treat obesity.
US researchers develop a dual-action cell therapy engineered to eliminate established tumours and train the immune system to eradicate primary tumour and prevent cancer’s recurrence.
Discover the Incucyte® Scratch Wound Analysis Software Module for automated image-based measurements of cell migration in vitro, using label-free analysis.